@article{fa5c4453101a42648d34272fe903fa59,
title = "Hormonal Contraception and Therapy Use in Breast Cancer Survivors: Do Recurrence or Mortality Risks Increase? [23A]",
keywords = "breast cancer, hormonal contraception, contraceptive counseling, menopausal symptoms",
author = "Sara Stanenas and Greer, \{Danielle M\} and Kram, \{Jessica J F\} and Tjoe, \{Judy A\} and Benjamin Dorton and \{Ob/Gyn Faculty\}, Aurora",
note = "We retrospectively studied women aged 18-55 years who were diagnosed with stage I-III breast cancer during 2006-2015 and entered remission. Multivariable extended proportional hazards models, supporting adjusted hazard ratio (HR), overall survival (OS), and locoregional and distant recurrence probability estimation, were used to examine the time-dependent effects of hormonal contraception (pill, patch, ring, subcutaneous device, injection, intrauterine device) and non-contraceptive hormonal therapies (e.g., menopausal symptoms), while adjusting for time-invariant patient, tumor, and treatment effects.",
year = "2017",
month = may,
day = "1",
doi = "10.1097/01.AOG.0000514257.49638.5b",
language = "American English",
journal = "Obstetrics \& Gynecology",
}